AI ECG monitoring to detect blood sugar changes in type 1
Part of Hormones & metabolism clinical trials.
This study tests an artificial intelligence tool that uses ECG (a heart tracing) to spot likely blood sugar changes in people with type 1 diabetes. It may help improve earlier detection of “glycaemic events” without invasive testing.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be an adult (18 or older) and live independently
- Have type 1 diabetes and be able to give written informed consent
- You should not be currently sick or undergoing other medical investigations
- No needle fear or strong anxiety about enclosed spaces (claustrophobia)
- Not take medicines that can interfere with heart-rate signals, like beta blockers
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses artificial intelligence to analyze glucose monitor data from people with type 1 diabetes. The goal is to find patterns that could improve care and treatment.
This study uses a wearable sensor (like a smartwatch) to track your body's signals when blood sugar drops low. The goal is to understand low blood sugar patterns better, which may help improve prevention and treatment.
This study watches blood sugar changes over time in people who do not yet have diabetes but have test results that suggest risk for type 1 diabetes. The goal is to see whether “blood sugar variability” can predict when high or low blood sugar may happen, even before symptoms.
This study uses a small wearable sensor that measures your blood sugar levels continuously for 14 days, combined with photos of your meals and activity records. Researchers will use artificial intelligence to analyze this data and create personalized nutrition recommendations tailored to your body's unique response to different foods.
This study tests a new automated insulin delivery (AID) system that connects your insulin pump to your glucose monitor to help keep your blood sugar in range. It is for both children and adults with type 1 diabetes who have not used an AID system before.
This study tests an upgraded automated insulin pump system that uses artificial intelligence to better predict and prevent blood sugar swings. If you have Type 1 Diabetes and already use an automated insulin pump, this trial may help you achieve better blood sugar control.
Hear when a new Metabolic Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.